Neurological Sciences

, Volume 39, Issue 9, pp 1565–1569 | Cite as

Expression analysis of beta-secretase 1 (BACE1) and its naturally occurring antisense (BACE1-AS) in blood of epileptic patients

  • Mehrdokht Mazdeh
  • Alireza Komaki
  • Mir Davood Omrani
  • Vajihe Gharzi
  • Arezou Sayad
  • Mohammad TaheriEmail author
  • Soudeh Ghafouri-FardEmail author
Original Article


Beta-secretase 1 (BACE1) gene encodes a transmembrane protease from the peptidase A1 family of aspartic proteases whose role in the pathogenesis of Alzheimer’s disease has been assessed. The enzymatic activity of BACE1 on several proteins implicated in epileptogenesis implies its role in the pathogenesis of epilepsy. In the present study, we assessed expression of BACE1 and its naturally occurring antisense (BACE1-AS) in peripheral blood of 40 epileptic patients and 40 age- and sex-matched healthy subjects. We did not detect either any difference in the expression of these genes between cases and controls or significant correlation between their expressions and participants’ age. However, we demonstrated a significant correlation between expression levels of BACE1 and BACE1-AS which supports the previously suggested feed-forward mechanism of regulation between these two transcripts. Future studies in larger sample sizes are needed to elaborate the function of BACE1 in epilepsy.


BACE1 BACE1-AS Epilepsy 


Funding information

The current study has been supported by a grant from the Hamadan University of Medical Sciences (Grant Number 9609286012).

Compliance with ethical standards

The local ethical committee of Hamadan University of Medical Sciences(IR.UMSHA.REC.1396.578)approved the study.

Conflict of interest

The authors declare that they have no conflict of interest.


  1. 1.
    Alfradique I, Vasconcelos MM (2007) Juvenile myoclonic epilepsy. Arq Neuropsiquiatr 65:1266–1271CrossRefPubMedGoogle Scholar
  2. 2.
    Chen Q, Liu X, Xu L, Wang Y, Wang S, Li Q, Huang Y, Liu T (2016) Long non-coding RNA BACE1-AS is a novel target for anisomycin-mediated suppression of ovarian cancer stem cell proliferation and invasion. Oncol Rep 35:1916–1924CrossRefPubMedGoogle Scholar
  3. 3.
    Decourt B, Sabbagh MN (2011) BACE1 as a potential biomarker for Alzheimer’s disease. J Alzheimers Dis 24:53–59CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    Engström PG, Suzuki H, Ninomiya N, Akalin A, Sessa L, Lavorgna G, Brozzi A, Luzi L, Tan SL, Yang L (2006) Complex loci in human and mouse genomes. PLoS Genet 2:e47CrossRefPubMedPubMedCentralGoogle Scholar
  5. 5.
    Fabene PF, Mora GN, Martinello M, Rossi B, Merigo F, Ottoboni L, Bach S, Angiari S, Benati D, Chakir A (2008) A role for leukocyte-endothelial adhesion mechanisms in epilepsy. Nat Med 14:1377–1383CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Faghihi MA, Modarresi F, Khalil AM, Wood DE, Sahagan BG, Morgan TE, Finch CE, Laurent GS III, Kenny PJ, Wahlestedt C (2008) Expression of a noncoding RNA is elevated in Alzheimer’s disease and drives rapid feed-forward regulation of β-secretase. Nat Med 14:723–730CrossRefPubMedPubMedCentralGoogle Scholar
  7. 7.
    Greco S, Zaccagnini G, Fuschi P, Voellenkle C, Carrara M, Sadeghi I, Bearzi C, Maimone B, Castelvecchio S, Stellos K (2017) Increased BACE1-AS long noncoding RNA and β-amyloid levels in heart failure. Cardiovasc Res 113:453–463CrossRefPubMedGoogle Scholar
  8. 8.
    Haass C, Schlossmacher MG, Hung AY, Vigo-Pelfrey C, Mellon A, Ostaszewski BL, Lieberburg I, Koo EH, Schenk D, Teplow DB (1992) Amyloid β-peptide is produced by cultured cells during normal metabolism. Nature 359:322–325CrossRefPubMedGoogle Scholar
  9. 9.
    Hitt BD, Jaramillo TC, Chetkovich DM, Vassar R (2010) BACE1−/−mice exhibit seizure activity that does not correlate with sodium channel level or axonal localization. Mol Neurodegener 5:31CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    Hu X, Hicks CW, He W, Wong P, Macklin WB, Trapp BD, Yan R (2006) Bace1 modulates myelination in the central and peripheral nervous system. Nat Neurosci 9:1520–1525CrossRefPubMedGoogle Scholar
  11. 11.
    Kearney JA (2017) Sodium channel β subunits in epilepsy: location, location, location. Epilepsy Curr 17:52–53CrossRefPubMedPubMedCentralGoogle Scholar
  12. 12.
    Kim DY, Carey BW, Wang H, Ingano LA, Binshtok AM, Wertz MH, Pettingell WH, He P, Lee VM-Y, Woolf CJ (2007) BACE1 regulates voltage-gated sodium channels and neuronal activity. Nat Cell Biol 9:755–764CrossRefPubMedPubMedCentralGoogle Scholar
  13. 13.
    Kim J, Yoon H, Chung DE, Brown JL, Belmonte KC, Kim J (2016) miR-186 is decreased in aged brain and suppresses BACE1 expression. J Neurochem 137:436–445CrossRefPubMedPubMedCentralGoogle Scholar
  14. 14.
    Lee H, Kim C, Ku J-L, Kim W, Yoon SK, Kuh H-J, Lee J-H, Nam SW, Lee EK (2014) A long non-coding RNA snaR contributes to 5-fluorouracil resistance in human colon cancer cells. Mol Cells 37:540–546CrossRefPubMedPubMedCentralGoogle Scholar
  15. 15.
    Li K-X, Lu Y-M, Xu Z-H, Zhang J, Zhu J-M, Zhang J-M, Cao S-X, Chen X-J, Chen Z, Luo J-H (2012) Neuregulin 1 regulates excitability of fast-spiking neurons through Kv1. 1 and acts in epilepsy. Nat Neurosci 15:267–273CrossRefGoogle Scholar
  16. 16.
    Lichtenthaler SF, Dominguez DI, Westmeyer GG, Reiss K, Haass C, Saftig P, De Strooper B, Seed B (2003) The cell adhesion protein P-selectin glycoprotein ligand-1 is a substrate for the aspartyl protease BACE1. J Biol Chem 278:48713–48719CrossRefPubMedGoogle Scholar
  17. 17.
    Minkeviciene R, Rheims S, Dobszay MB, Zilberter M, Hartikainen J, Fulop L, Penke B, Zilberter Y, Harkany T, Pitkanen A, Tanila H (2009) Amyloid beta-induced neuronal hyperexcitability triggers progressive epilepsy. J Neurosci 29:3453–3462CrossRefPubMedGoogle Scholar
  18. 18.
    Nalivaeva NN, Belyaev ND, Turner AJ (2009) Sodium valproate: an old drug with new roles. Trends Pharmacol Sci 30:509–514CrossRefPubMedGoogle Scholar
  19. 19.
    Qing H, He G, Ly PT, Fox CJ, Staufenbiel M, Cai F, Zhang Z, Wei S, Sun X, Chen C-H (2008) Valproic acid inhibits Aβ production, neuritic plaque formation, and behavioral deficits in Alzheimer’s disease mouse models. J Exp Med 205:2781–2789CrossRefPubMedPubMedCentralGoogle Scholar
  20. 20.
    Seubert P, Oltersdorf T, Lee MG, Barbour R, Blomquist C, Davis DL, Bryant K, Fritz LC, Galasko D, Thal LJ (1993) Secretion of β-amyloid precursor protein cleaved at the amino terminus of the β-amyloid peptide. Nature 361:260–263CrossRefPubMedGoogle Scholar
  21. 21.
    Sima X, Xu J, Li J, Zhong W, You C (2014) Expression of β-amyloid precursor protein in refractory epilepsy. Mol Med Rep 9:1242–1248CrossRefPubMedGoogle Scholar
  22. 22.
    Vassar R (2002) β-Secretase (BACE) as a drug target for Alzheimer’s disease. Adv Drug Deliv Rev 54:1589–1602CrossRefPubMedGoogle Scholar
  23. 23.
    Vassar R, Cole S (2007) The basic biology of BACE1: a key therapeutic target for Alzheimer’s disease. Curr Genomics 8:509–530CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer-Verlag Italia S.r.l., part of Springer Nature 2018

Authors and Affiliations

  1. 1.Neurophysiology Research CenterHamadan University of Medical SciencesHamadanIran
  2. 2.Department of NeurologyHamadan University of Medical SciencesHamadanIran
  3. 3.Department of Medical GeneticsShahid Beheshti University of Medical SciencesTehranIran
  4. 4.Urogenital Stem Cell Research CenterShahid Beheshti University of Medical SciencesTehranIran

Personalised recommendations